AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32449919 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired BP recovery (systolic)
Number of subjects: 55
Study 32449919 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired BP recovery (diastolic)
Number of subjects: 55
Study 34166030 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Foundations Home Visiting (FFHV) - 11 in-home sessions focusing on parental cooperation, collaboration, and conflict management
Number of subjects: 150
Study 34166030 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Foundations Home Visiting (FFHV)
Number of subjects: 150
Study 33559851 — intervention group
Group type: EXPERIMENTAL
Intervention: OL-HDFcit (dialysate containing one mmol of citric acid)
Number of subjects: 47
Study 33559851 — intervention group
Group type: COMPARATOR
Intervention: OL-HDFst (standard dialysate containing three mmol of acetic acid)
Number of subjects: 47
Study 33559851 — intervention group
Group type: EXPERIMENTAL
Intervention: OL-HDFcit
Number of subjects: 47
Study 33559851 — intervention group
Group type: COMPARATOR
Intervention: OL-HDFst
Number of subjects: 47
Study 32473817 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment centers in Upper Egypt
Number of subjects: 24
Study 32473817 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment centers
Number of subjects: 24
Study 32473817 — intervention group
Group type: EXPERIMENTAL
Intervention: Monfiya Governorate (Lower Egypt) and Aswan (Upper Egypt)
Number of subjects: 24
Study 32473817 — intervention group
Group type: EXPERIMENTAL
Intervention: Kalyoubia (Lower Egypt) and Sohag Governorate (Upper Egypt)
Number of subjects: 24
Study 32473817 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall performance of treatment centers
Number of subjects: 24
Study 36457343 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV exercise with surgical mask
Number of subjects: 47
Study 36457343 — intervention group
Group type: COMPARATOR
Intervention: WBV exercise without surgical mask
Number of subjects: 47
Study 36457343 — intervention group
Group type: EXPERIMENTAL
Intervention: Different vibration frequency protocols (A, B, C)
Number of subjects: 47
Study 33452201 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week telehealth CBT
Number of subjects: 80
Study 33452201 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week telehealth CBT
Number of subjects: 80
Study 33452201 — intervention group
Group type: COMPARATOR
Intervention: no-CBT
Number of subjects: 80
Study 32441302 — intervention group
Group type: EXPERIMENTAL
Intervention: Costoclavicular approach (CC) with modified double-injection technique
Number of subjects: 112
Study 32441302 — intervention group
Group type: COMPARATOR
Intervention: Supraclavicular approach (SC) with modified double-injection technique
Number of subjects: 112
Study 36316075 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive total gastrectomy (MIG)
Number of subjects: 160
Study 36316075 — intervention group
Group type: COMPARATOR
Intervention: Open total gastrectomy (OG)
Number of subjects: 160
Study 36451509 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable microneedle acupuncture (BMA)
Number of subjects: 30
Study 36451509 — intervention group
Group type: COMPARATOR
Intervention: Conventional intradermal acupuncture
Number of subjects: 30
Study 33624081 — intervention group
Group type: EXPERIMENTAL
Intervention: Boosted protease inhibitor (bPI) plus lamivudine dual therapy
Number of subjects: 265
Study 33624081 — intervention group
Group type: COMPARATOR
Intervention: Boosted protease inhibitor (bPI) monotherapy
Number of subjects: 265
Study 33624081 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (bPI + lamivudine)
Number of subjects: 265
Study 32054059 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump-in intervention
Number of subjects: 0
Study 34027782 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley’s‐misoprostol (25 µg vaginal misoprostol tablet)
Number of subjects: 150
Study 34027782 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley’s‐dinoprostone (0.5 mg intracervical dinoprostone gel)
Number of subjects: 150
Study 34658941 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteine-rich whey protein (CRWP) 0.5 g/kg for children <20 kg or 10 g for those >20 kg
Number of subjects: 46
Study 34658941 — intervention group
Group type: COMPARATOR
Intervention: Placebo (rice protein)
Number of subjects: 46
Study 32679021 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine plus JPJDF (Flu-F-treated group, n = 69)
Number of subjects: 137
Study 32679021 — intervention group
Group type: COMPARATOR
Intervention: Fluoropyrimidine (Flu-treated group, n = 68)
Number of subjects: 137
Study 35763390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU/day
Number of subjects: 635
Study 34200027 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Low-Carbohydrate (HLC) diet
Number of subjects: 609
Study 34200027 — intervention group
Group type: COMPARATOR
Intervention: Healthy Low-Fat (HLF) diet
Number of subjects: 609
Study 34989325 — intervention group
Group type: EXPERIMENTAL
Intervention: RADoralex®
Number of subjects: 90
Study 34989325 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate solution
Number of subjects: 90
Study 32587272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical decompression surgery
Number of subjects: 53
Study 32587272 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 53
Study 33196779 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (n = 69)
Number of subjects: 154
Study 33196779 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention (n = 85)
Number of subjects: 154
Study 37658343 — intervention group
Group type: EXPERIMENTAL
Intervention: MOHMQuit intervention
Number of subjects: 0
Study 37658343 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33399174 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR‐MCCD
Number of subjects: 32
Study 33399174 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR‐S
Number of subjects: 32
Study 33399174 — intervention group
Group type: COMPARATOR
Intervention: CPR‐W
Number of subjects: 32
Study 34013839 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Citrulline supplementation
Number of subjects: 10
Study 36249264 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin imagery
Number of subjects: 72
Study 36249264 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 72
Study 36249264 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study 33741039 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin supplementation
Number of subjects: 375
Study 33741039 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 (SYN-1)
Number of subjects: 375
Study 33741039 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 (SYN-1) and VE-cadherin
Number of subjects: 375
Study 33741039 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 (SYN-1) and Sphingosine-1-phosphate (S1P)
Number of subjects: 375
Study 33741039 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphingosine-1-phosphate (S1P)
Number of subjects: 375
Study 32400728 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 78
Study 32400728 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic inhibition muscle energy technique
Number of subjects: 78
Study 32400728 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocal inhibition muscle energy technique
Number of subjects: 78
Study 35165776 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral exoskeleton
Number of subjects: 0
Study 35165776 — intervention group
Group type: COMPARATOR
Intervention: No exoskeleton
Number of subjects: 0
Study 32062864 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 80
Study 32062864 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS combined with general anesthesia
Number of subjects: 80
Study 33260196 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (daily sessions for one week)
Number of subjects: 34
Study 33260196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoga intervention)
Number of subjects: 34
Study 35393979 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan-coated Chamomilla recutita microparticles
Number of subjects: 54
Study 35393979 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study 34019729 — intervention group
Group type: EXPERIMENTAL
Intervention: DGC-CC
Number of subjects: 150
Study 34019729 — intervention group
Group type: COMPARATOR
Intervention: DGC
Number of subjects: 150
Study 34019729 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study 35121249 — intervention group
Group type: EXPERIMENTAL
Intervention: PPN-DBS
Number of subjects: 6
Study 35121249 — intervention group
Group type: EXPERIMENTAL
Intervention: CuN-DBS
Number of subjects: 6
Study 35121249 — intervention group
Group type: COMPARATOR
Intervention: Off-DBS
Number of subjects: 6
Study 34262678 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg daily)
Number of subjects: 50
Study 34262678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 36294864 — intervention group
Group type: COMPARATOR
Intervention: 0.12% Chlorhexidine (CHX) mouthwash applied twice a day for 7 days
Number of subjects: 81
Study 36294864 — intervention group
Group type: EXPERIMENTAL
Intervention: New Bone Bioactive Liquid (BBL) mouthwash applied twice a day for 7 days
Number of subjects: 81
Study 34880122 — intervention group
Group type: EXPERIMENTAL
Intervention: Text warning labels (WL) on e-liquid vials
Number of subjects: 313
Study 34880122 — intervention group
Group type: COMPARATOR
Intervention: No text warning labels (WL) on e-liquid vials
Number of subjects: 313
Study 35065101 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured individualized education combined with real‐time continuous glucose monitoring (rt‐CGM)
Number of subjects: 47
Study 35065101 — intervention group
Group type: COMPARATOR
Intervention: Real‐time continuous glucose monitoring (rt‐CGM) alone (control group)
Number of subjects: 47
Study 33546020 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection combined with furosemide
Number of subjects: 0
Study 33546020 — intervention group
Group type: COMPARATOR
Intervention: Simple furosemide
Number of subjects: 0
Study 32501109 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary arthrodesis (PA) of the medial 3 TMT joints
Number of subjects: 48
Study 32501109 — intervention group
Group type: COMPARATOR
Intervention: Temporary bridge plate (BP) over the first TMT joint and primary arthrodesis of the second and third TMT joints
Number of subjects: 48
Study 34719869 — intervention group
Group type: EXPERIMENTAL
Intervention: ADEB (standard chemotherapy plus bortezomib)
Number of subjects: 483
Study 34719869 — intervention group
Group type: COMPARATOR
Intervention: ADE (standard chemotherapy without bortezomib)
Number of subjects: 483
Study 33301814 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 319
Study 33301814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (SRT)
Number of subjects: 319
Study 33301814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (COMB)
Number of subjects: 319
Study 33301814 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 319
Study 33301814 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall service use
Number of subjects: 319
Study 35013762 — intervention group
Group type: EXPERIMENTAL
Intervention: avoidance‐AAT
Number of subjects: 124
Study 35013762 — intervention group
Group type: EXPERIMENTAL
Intervention: inhibition‐AAT
Number of subjects: 124
Study 35013762 — intervention group
Group type: COMPARATOR
Intervention: sham‐avoidance‐AAT
Number of subjects: 124
Study 35013762 — intervention group
Group type: COMPARATOR
Intervention: sham‐inhibition‐AAT
Number of subjects: 124
Study 35013762 — intervention group
Group type: EXPERIMENTAL
Intervention: all training conditions
Number of subjects: 124
Study 32070444 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum copeptin levels
Number of subjects: 76
Study 32070444 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum hs‐cTnI levels
Number of subjects: 76
Study 32070444 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean CPR duration
Number of subjects: 76
Study 32070444 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum glucose, CK‐MB levels, arterial blood gas levels
Number of subjects: 76
Study 34283838 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization of the sequence of events in coinfection process
Number of subjects: 3
Study 34283838 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization of the sequence of events in independent infection dynamics
Number of subjects: 3
Study 34283838 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization of daily pattern correlations
Number of subjects: 3
Study 34283838 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean outbreak size
Number of subjects: 3
Study 34283838 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact randomization at organizational level
Number of subjects: 3
Study 35788794 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Family Partnership program (n=3806)
Number of subjects: 5670
Study 35788794 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care services, n=1864)
Number of subjects: 5670
Study 33945977 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital otoscope (Cellscope Oto)
Number of subjects: 188
Study 33945977 — intervention group
Group type: COMPARATOR
Intervention: Traditional otoscope
Number of subjects: 188
Study 32067261 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive-based psychotherapy plus standard case management
Number of subjects: 147
Study 32067261 — intervention group
Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 147
Study 34983553 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy-enhancing intervention (SEEI) comprising personalized exercise guidance and self-efficacy education delivered via one face-to-face education session and four telephone consultations, supplemented by written materials.
Number of subjects: 150
Study 34983553 — intervention group
Group type: COMPARATOR
Intervention: Usual care using evidence-based guidelines (Control group)
Number of subjects: 150
Study 32926803 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoadjusting CPAP (4‐20 cm H2O)
Number of subjects: 120
Study 32926803 — intervention group
Group type: COMPARATOR
Intervention: Subtherapeutic CPAP (pressure fixed at 4 cm H2O)
Number of subjects: 120
Study 32217739 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg melatonin
Number of subjects: 99
Study 32217739 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg melatonin
Number of subjects: 99
Study 32217739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 32217739 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 99
Study 36284289 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth of anesthesia set to BIS 55 (group H)
Number of subjects: 80
Study 36284289 — intervention group
Group type: COMPARATOR
Intervention: Depth of anesthesia set to BIS 45 (group L)
Number of subjects: 80
Study 33689150 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate exercise intervention
Number of subjects: 60
Study 33689150 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 60
Study 32738208 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + LVA ablation
Number of subjects: 145
Study 32738208 — intervention group
Group type: COMPARATOR
Intervention: PVI only (Control)
Number of subjects: 145
Study 36115497 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil (high dose, ≥9 breaths per session)
Number of subjects: 335
Study 36115497 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil (low dose, <9 breaths per session)
Number of subjects: 335
Study 36115497 — intervention group
Group type: COMPARATOR
Intervention: Placebo (high dose)
Number of subjects: 335
Study 36115497 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low dose)
Number of subjects: 335
Study 33085510 — intervention group
Group type: EXPERIMENTAL
Intervention: BFF (BreastFeeding Friend) app
Number of subjects: 87
Study 32542307 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 273
Study 32542307 — intervention group
Group type: COMPARATOR
Intervention: 800 IU vitamin D3
Number of subjects: 273
Study 35347597 — intervention group
Group type: EXPERIMENTAL
Intervention: R-score (radiomics signature)
Number of subjects: 332
Study 35347597 — intervention group
Group type: EXPERIMENTAL
Intervention: R-fibrosis (integrated radiomic and serum variables)
Number of subjects: 332
Study 35347597 — intervention group
Group type: COMPARATOR
Intervention: aspartate transaminase-to-platelet ratio (APRI)
Number of subjects: 332
Study 35347597 — intervention group
Group type: COMPARATOR
Intervention: fibrosis-4 index (FIB-4)
Number of subjects: 332
Study 34797419 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial oocyte activation (AOA)
Number of subjects: 140
Study 32524985 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting with mitral valve repair (Group 1)
Number of subjects: 60
Study 32524985 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting only (Group 2)
Number of subjects: 60
Study 34820974 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of carboxytherapy and narrowband-ultraviolet B (NB-UVB)
Number of subjects: 28
Study 34820974 — intervention group
Group type: COMPARATOR
Intervention: Narrowband-ultraviolet B (NB-UVB) alone
Number of subjects: 28
Study 34348654 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifid triple viable capsules (420 mg, 3 times a day for 2 months)
Number of subjects: 130
Study 34348654 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine plus somatostatin
Number of subjects: 130
Study 33908295 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 33
Study 33908295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32320139 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure for 10 minutes before venipuncture
Number of subjects: 90
Study 32320139 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupressure)
Number of subjects: 90
Study 36281472 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivanib+Cetuximab
Number of subjects: 750
Study 36281472 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab+Placebo
Number of subjects: 750
Study 33855080 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 71
Study 33855080 — intervention group
Group type: COMPARATOR
Intervention: Control (fixed dose of 1000 mL crystalloid fluid)
Number of subjects: 71
Study 34906619 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular single-implant overdentures (1-IODs)
Number of subjects: 22
Study 34906619 — intervention group
Group type: COMPARATOR
Intervention: Experimental removable complete dentures (eRCDs)
Number of subjects: 22
Study 33980519 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus an intervention delivered by trained community health workers (non‐specialists)
Number of subjects: 242
Study 33980519 — intervention group
Group type: COMPARATOR
Intervention: Usual care (waiting‐list)
Number of subjects: 242
Study 35277369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME) from 20 weeks gestation until birth
Number of subjects: 200
Study 35277369 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal care only (Control Group)
Number of subjects: 200
Study 35277369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME)
Number of subjects: 200
Study 32527501 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg kg−1 methylprednisolone in 5 mL of saline
Number of subjects: 162
Study 32527501 — intervention group
Group type: COMPARATOR
Intervention: 5 mL of saline (Control Group)
Number of subjects: 162
Study 35027153 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation-focused therapy
Number of subjects: 147
Study 35027153 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal-focused therapy
Number of subjects: 147
Study 35027153 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (Control)
Number of subjects: 147
Study 33104519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rg1 (5 mg, an immunostimulant ginsenoside)
Number of subjects: 0
Study 33104519 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 0
Study 32372215 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (20 mg)
Number of subjects: 50
Study 34309859 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-Denmark vaccination
Number of subjects: 1272
Study 34309859 — intervention group
Group type: COMPARATOR
Intervention: Control (no BCG vaccination)
Number of subjects: 1272
Study 34309859 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-Denmark vaccination in high-risk infants
Number of subjects: 1272
Study 34309859 — intervention group
Group type: COMPARATOR
Intervention: Control (no BCG vaccination) in high-risk infants
Number of subjects: 1272
Study 34414949 — intervention group
Group type: EXPERIMENTAL
Intervention: ART-added physiotherapy
Number of subjects: 70
Study 34414949 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 70
Study 35365305 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP‐KOA (internet‐based exercise training program, phone counseling, physical therapy)
Number of subjects: 345
Study 35365305 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP‐KOA
Number of subjects: 345
Study 35365305 — intervention group
Group type: COMPARATOR
Intervention: Control (arthritis education)
Number of subjects: 345
Study 33678513 — intervention group
Group type: EXPERIMENTAL
Intervention: Edasalonexent 100 mg/kg/day
Number of subjects: 0
Study 33678513 — intervention group
Group type: EXPERIMENTAL
Intervention: Edasalonexent 67 mg/kg/day
Number of subjects: 0
Study 33678513 — intervention group
Group type: COMPARATOR
Intervention: Placebo or off-treatment control
Number of subjects: 0
Study 32702697 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle calyx entry (group 1)
Number of subjects: 70